Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (2 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (2)
Type
(
1 selected
)
Type
Guidance (750)
Guidance programme
(
1 selected
)
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (224)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (17)
Highly specialised technologies guidance (27)
Interventional procedures guidance (598)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (340)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (750)
Apply filters
Showing 1 to 10 of 750
Sort by
Date
Title
Apply sorting
Type: Guidance
Remove Type: Guidance filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Cabozantinib with nivolumab for untreated advanced renal cell carcinoma
TA964
10 April 2024
10 April 2024
Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
TA963
3 April 2024
3 April 2024
Sebelipase alfa for treating lysosomal acid lipase deficiency that is not Wolman disease (terminated appraisal)
TA961
28 March 2024
28 March 2024
Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy
TA962
28 March 2024
28 March 2024
Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal)
TA965
28 March 2024
28 March 2024
Ritlecitinib for treating severe alopecia areata in people 12 years and over
TA958
27 March 2024
27 March 2024
Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis
TA959
27 March 2024
27 March 2024
Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal)
TA960
27 March 2024
27 March 2024
Momelotinib for treating myelofibrosis-related splenomegaly or symptoms
TA957
20 March 2024
20 March 2024
Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
TA878
29 March 2023
13 March 2024
Current page
1
2
3
…
75
Page
1
of
75
Next page
Results per page
10
25
50
All
Back to top